Publication | Open Access
Acyl-CoA: cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT
38
Citations
0
References
1992
Year
Mevalonate Derivative 2PharmacotherapyLow DensityChemical BiologyPharmaceutical ChemistryOxidative StressMedicinal ChemistryDietary CholesterolAtherosclerosisInhibitory ActivityDyslipidemiaLipid DisorderOxysterolBiochemistryVascular BiologyPharmacologyCholesterol O-acyl TransferaseNatural SciencesPhysiologyPotent InhibitorsMedicineDrug Discovery
A potent, bioavailable ACAT inhibitor may have beneficial effects in the treatment of atherosclerosis by (i) reducing the absorption of dietary cholesterol, (ii) reducing the secretion of very low density lipoproteins into plasma from the liver, and (iii) preventing the transformation of arterial macrophages into foam cells. We have found that a mevalonate derivative 2, which contains a 4,5-diphenyl-1H-imidazol-2-yl moiety, inhibits rat hepatic microsomal ACAT in vitro and produces a significant hypocholesterolemic effect in the cholesterol-fed rat. Structure-activity relationships for analogues of 2 demonstrate that the 4,5-diphenyl-1H-imidazole moiety is a pharmacophore for inhibition of rat microsomal ACAT.